These final results, along with a former report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 support the thought of focusing on ACKR3 as a singular strategy to modulate the opioid method, which could open up new therapeutic avenues for opioid-associated Diseases. Along with the https://edenw370bfj0.iyublog.com/profile